↓ Skip to main content

Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms

Overview of attention for article published in Hematological Oncology, August 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms
Published in
Hematological Oncology, August 2018
DOI 10.1002/hon.2537
Pubmed ID
Authors

Tariq I. Mughal, Thomas Lion, Omar Abdel‐Wahab, Ruben Mesa, Robyn M. Scherber, Danilo Perrotti, Michael Mauro, Srdan Verstovsek, Giuseppe Saglio, Richard A. Van Etten, Robert Kralovics

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 21%
Other 2 11%
Student > Master 2 11%
Researcher 2 11%
Student > Bachelor 1 5%
Other 2 11%
Unknown 6 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 32%
Medicine and Dentistry 2 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Psychology 1 5%
Nursing and Health Professions 1 5%
Other 2 11%
Unknown 6 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2018.
All research outputs
#18,646,262
of 23,099,576 outputs
Outputs from Hematological Oncology
#998
of 1,181 outputs
Outputs of similar age
#254,520
of 331,039 outputs
Outputs of similar age from Hematological Oncology
#18
of 20 outputs
Altmetric has tracked 23,099,576 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,181 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,039 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.